Real-time PCR assays for genotyping of Cryptococcus gattii in North America
Authors:
- Erin J KelleyEKErin J Kelley
- Elizabeth M DriebeEDElizabeth M Driebe
- Kizee EtienneKEKizee Etienne
- Mary E BrandtMBMary E Brandt
- James M SchuppJSJames M Schupp
- John D GilleceJGJohn D Gillece
- Jesse S TrujilloJTJesse S Trujillo
- Shawn R LockhartShawn R Lockhart
- Eszter DeakEDEszter Deak
- Paul S KeimPKPaul S Keim
- David M EngelthalerDEDavid M Engelthaler
Open Access
- 1 January 2014
- journal article
- research article
- Published by Springer Nature in BMC Microbiology
- Vol. 14 (1) , 125
Abstract
Cryptococcus gattii has been the cause of an ongoing outbreak starting in 1999 on Vancouver Island, British Columbia and spreading to mainland Canada and the US Pacific Northwest. In the course of the outbreak, C. gattii has been identified outside of its previously documented climate, habitat, and host disease. Genotyping of C. gattii is essential to understand the ecological and geographical expansion of this emerging pathogen. We developed and validated a mismatch amplification mutation assay (MAMA) real-time PCR panel for genotyping C. gattii molecular types VGI-VGIV and VGII subtypes a,b,c. Subtype assays were designed based on whole-genome sequence of 20 C. gattii strains. Publically available multilocus sequence typing (MLST) data from a study of 202 strains was used for the molecular type (VGI-VGIV) assay design. All assays were validated across DNA from 112 strains of diverse international origin and sample types, including animal, environmental and human. Validation revealed each assay on the panel is 100% sensitive, specific and concordant with MLST. The assay panel can detect down to 0.5 picograms of template DNA. The (MAMA) real-time PCR panel for C. gattii accurately typed a collection of 112 diverse strains and demonstrated high sensitivity. This is a time and cost efficient method of genotyping C. gattii best suited for application in large-scale epidemiological studies.Keywords
This publication has 23 references indexed in Scilit:
- MALDI-TOF MS Enables the Rapid Identification of the Major Molecular Types within the Cryptococcus neoformans/C. gattii Species ComplexPLOS ONE, 2012
- Melt Analysis of Mismatch Amplification Mutation Assays (Melt-MAMA): A Functional Study of a Cost-Effective SNP Genotyping Assay in Bacterial ModelsPLOS ONE, 2012
- Fatal Disseminated Cryptococcus gattii Infection in New MexicoPLOS ONE, 2011
- Whole Genome Sequence Analysis of Cryptococcus gattii from the Pacific Northwest Reveals Unexpected DiversityPLOS ONE, 2011
- High-Resolution Melting Analysis for Identification of the Cryptococcus neoformans-Cryptococcus gattii ComplexJournal of Clinical Microbiology, 2011
- Genome Variation in Cryptococcus gattii, an Emerging Pathogen of Immunocompetent HostsmBio, 2011
- In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus gattii IsolatesAntimicrobial Agents and Chemotherapy, 2010
- Correlation of Genotype and In Vitro Susceptibilities of Cryptococcus gattii Strains from the Pacific Northwest of the United StatesJournal of Clinical Microbiology, 2010
- Molecular Evidence That the Range of the Vancouver Island Outbreak ofCryptococcus gattiiInfection Has Expanded into the Pacific Northwest in the United StatesThe Journal of Infectious Diseases, 2009
- Consensus multi-locus sequence typing scheme forCryptococcus neoformansandCryptococcus gattiiMedical Mycology, 2009